Please Wait
Applying Filters...
menu
    • menu

    List of Certificates of Suitability (CEPs) for 07741_FLUKA Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Email Product
    US, Europe turn to advanced manufacturing, stockpiling to strengthen drug supply chains

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Sept 2024: BMS wins landmark FDA approval for schizophrenia med; Sanofi’s Dupixent okayed for COPD

    Stock Recap
    #PipelineProspector

    Menu

    07741_FLUKA

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 263,673Xls download

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Certificate Holder Certificate No. Substance Issue Date Status Type End Date Substance No.
    26/09/2024 Farmhispania
    Spain
    		 Farmhispania, S.A. Montmeló ES R0-CEP 2019-256 - Rev 02 Everolimus, 2.0% BHT 2023-04-27 Valid Chemical 2918
    26/09/2024 Chunghwa Chemical Synthesis & Biotech
    Taiwan
    		 Chunghwa Chemical Synthesis & Biotech Co., Ltd. Shu-Lin TW CEP 2021-192 - Rev 02 Everolimus, With antioxidant butylhydroxytoluene 2.0% 2024-02-22 Valid Chemical 2918